Market Tracker

09/22 3:36am ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.5045
Delayed Data
As of Sep 21
 -0.0145 / -2.79%
Today’s Change
0.48
Today|||52-Week Range
2.93
-29.41%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.52
Today’s open0.52
Day’s range0.49 - 0.53
Volume281,169
Average volume (3 months)234,523
Market cap$12.1M
Dividend yield--
Data as of 3:58pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
NDRAENDRA Life Sciences ...-0.43-11.31%
XTNTXtant Medical Holdin...+0.00+0.56%
GENEGenetic Technologies...-0.02-2.29%
SNGXSoligenix Inc-0.05-2.22%
Data as of 3:59pm ET, 09/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts